Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Orange, California and other locations
Dates
study started
completion around

Description

Summary

The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.

Official Title

HEALEY ALS Platform Trial

Details

Keywords

Amyotrophic Lateral Sclerosis, ALS, Placebo-Controlled, Double-Blind, Master Protocol, Lou Gehrig's Disease, Motor Neuron Disease, ABBV-CLS-7262, DNL343

Eligibility

Locations

  • University of California, Irvine
    Orange California 92868 United States
  • University of Southern California
    Los Angeles California 90033 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Merit E. Cudkowicz, MD
ID
NCT04297683
Phase
Phase 2/3 Amyotropic Lateral Sclerosis (ALS) Research Study
Study Type
Interventional
Participants
Expecting 1500 study participants
Last Updated